معرفی
Professor Geoffrey McCaughan holds the W Morrow Professorship in Medicine at the University of Sydney's Central Clinical School. He is affiliated with the Centenary Institute of Cancer Medicine & Cell Biology and collaborates with institutions like the National Health and Medical Research Council (NHMRC). His research focuses on liver transplantation tolerance mechanisms, hepatocellular carcinoma (HCC), immune tolerance pathways, and translational applications of normothermic machine perfusion. He has contributed to studies on biliary injury prevention, HCC recurrence, and the impact of geographic access on transplant outcomes.
His educational background and prior roles are not explicitly detailed in the text, but his work spans clinical and experimental hepatology, with expertise in viral hepatitis (especially HCV), liver immunology, and organ preservation technologies. Key research approaches include animal models, molecular proteomics, and clinical trial designs.
McCaughan leads investigations into vascular and metabolic factors in liver disease, such as the role of sphingosine kinase in tumor growth and the influence of DPP4/DPP9 enzymes on fibrosis and cancer progression. He actively participates in national and international collaborations, including the INTERLIVER study on molecular rejection diagnosis and the APRICA trial on palliative care integration for HCC patients.
In advising, he supervises Mingchang ZHANG's research on liver cancer and hepatitis. His work emphasizes improving graft quality, addressing immunosuppression challenges, and optimizing transplant criteria. He is also involved in translational research to expand donor liver utilization through split-liver techniques and ex vivo perfusion systems. Collaborations include teams at the Centenary Institute and the National Liver Transplant Service.